Trial Profile
Clinical Trials Insight: 700040805
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Jan 2010
Price :
$35
*
At a glance
- Drugs MCD 386 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors Mithridion
- 10 Jul 2008 New trial record.